13,500,000 Shares ONCOTHYREON INC. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • February 6th, 2015 • Oncothyreon Inc. • Services-commercial physical & biological research • New York
1,333 Shares ONCOTHYREON INC. Series B Convertible Preferred Stock UNDERWRITING AGREEMENTUnderwriting Agreement • February 6th, 2015 • Oncothyreon Inc. • Services-commercial physical & biological research • New York
ONCOTHYREON INC. SECURITIES EXCHANGE AGREEMENTSecurities Exchange Agreement • February 6th, 2015 • Oncothyreon Inc. • Services-commercial physical & biological research • Delaware
This Securities Exchange Agreement (this “Agreement”) is made as of February 5, 2015 (the “Effective Date”) by and between ONCOTHYREON INC., a Delaware corporation (the “Company”), and BIOTECHNOLOGY VALUE FUND, L.P., a Delaware limited partnership, and BIOTECHNOLOGY VALUE FUND II, L.P., a Delaware limited partnership (each a “Holder” and, collectively, the “Holders”).
